Nov 11 2005 | 9:22pm ET
Scott Moonly has been appointed v.p. of life science investments for Brookstone Capital, which specializes in alternative investment opportunities.
Moonly, who joins the firm from L.E.K. Consulting, will be responsible for identifying life science investment opportunities and performing due diligence on both private and public companies. He holds a Ph.D. in biomedical engineering.
In addition to working at L.E.K. Consulting, Moonly has served as an investment analyst with the Merrill Lynch Healthcare Group where he provided financial and strategic analysis for biotechnology and medical device companies. Brookstone has offices in Costa Mesa, Calif. and Las Vegas.
Jan 30 2018 | 9:49pm ET
As the U.S. shifts from monetary stimulus to fiscal stimulus, market pricing should...
May 24 2017 | 9:25pm ET
Starting in 2019, financial industry executives sitting for the coveted Chartered...
Feb 14 2018 | 9:57pm ET
Tasked with delivering returns on client capital, a common dilemma for many alternative...